Back to Search
Start Over
Melatonin: Pharmacology, Functions and Therapeutic Benefits
- Source :
- Current Neuropharmacology, Current Neuropharmacology, Bentham Science Publishers, 2017, 15 (3), pp.434--443. ⟨10.2174/1570159X14666161228122115⟩, Current Neuropharmacology, 2017, 15 (3), pp.434--443. ⟨10.2174/1570159X14666161228122115⟩, Current Neuropharmacology, Bentham Science Publishers, 2017, 15 (3), pp.434--443. 〈10.2174/1570159X14666161228122115〉
- Publication Year :
- 2017
- Publisher :
- HAL CCSD, 2017.
-
Abstract
- International audience; Background: Melatonin synchronizes central but also peripheral oscillators (fetal adrenal gland, pancreas, liver, kidney, heart, lung, fat, gut, etc.), allowing temporal organization of biological functions through circadian rhythms (24-hour cycles) in relation to periodic environmental changes and therefore adaptation of the individual to his/her internal and external environment. Measures of melatonin are considered the best peripheral indices of human circadian timing based on an internal 24-hour clock. Methods: First, the pharmacology of melatonin (biosynthesis and circadian rhythms, pharmacokinetics and mechanisms of action) is described, allowing a better understanding of the short and long term effects of melatonin following its immediate or prolonged release. Then, research related to the physiological effects of melatonin is reviewed. Results: The physiological effects of melatonin are various and include detoxification of free radicals and antioxidant actions, bone formation and protection, reproduction, and cardiovascular, immune or body mass regulation. Also, protective and therapeutic effects of melatonin are reported, especially with regard to brain or gastrointestinal protection, psychiatric disorders, cardiovascular diseases and oncostatic effects. Conclusion: This review highlights the high number and diversity of major melatonin effects and opens important perspectives for measuring melatonin as a biomarker (biomarker of early identification of certain disorders and also biomarker of their follow-up) and using melatonin with clinical preventive and therapeutic applications in newborns, children and adults based on its physiological regulatory effects.
- Subjects :
- 0301 basic medicine
synchronizer
[SDV]Life Sciences [q-bio]
melatonin
Pharmacology
Biology
Antioxidants
Article
sleep-wake rhythm
Melatonin
03 medical and health sciences
0302 clinical medicine
Immune system
prevention and treatment
Pharmacokinetics
Prolonged release
Detoxification
medicine
Animals
Humans
Pharmacology (medical)
Circadian rhythm
central and peripheral oscillators
Kidney
[ SDV ] Life Sciences [q-bio]
Mental Disorders
Brain
General Medicine
adaptation to external and internal environment
3. Good health
Circadian Rhythm
Psychiatry and Mental health
Biomarker
clinical application
030104 developmental biology
medicine.anatomical_structure
Neurology
biomarker
Neurology (clinical)
030217 neurology & neurosurgery
hormones, hormone substitutes, and hormone antagonists
biological clocks
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 1570159X
- Database :
- OpenAIRE
- Journal :
- Current Neuropharmacology, Current Neuropharmacology, Bentham Science Publishers, 2017, 15 (3), pp.434--443. ⟨10.2174/1570159X14666161228122115⟩, Current Neuropharmacology, 2017, 15 (3), pp.434--443. ⟨10.2174/1570159X14666161228122115⟩, Current Neuropharmacology, Bentham Science Publishers, 2017, 15 (3), pp.434--443. 〈10.2174/1570159X14666161228122115〉
- Accession number :
- edsair.doi.dedup.....bcd949d4d943764447dabc1be9fcd36d